All Work

Douglas A. McIntyre

Full Analyst Research Summary (MAR 30, 2007)

ANAD started as Outperform at Credit Suisse.ASCA cut to Underweight at Prudential.AU cut to Neutral at HSBC.BELM cut to Neutral at Baird.BRCM raised to Buy at Stifel Nicolaus.

Douglas A. McIntyre · 20 years ago

Will Vodafone’s Troubles Hit US Cell Companies?

Vodafone (VOD) mostly operates in the mature European markets. It holds a big stake in Verizon (VZ) Wireless. Today is announced competitive pressures, dropping prices and regulatory issues were hurting its financial margins. As…

Douglas A. McIntyre · 20 years ago

Pre-Market Stock News (MAR 30, 2007)

(ACOR) Acorda positive in MS treatments in Business Week.(BGP) Borders is reportedly in talks tyo sell its book store operations in the UK to Richard Branson’s Virgin.(DELL) Dell fell 5% on 10-K delay over…

Douglas A. McIntyre · 20 years ago

Dell Accounting: Taking The Eye Off The Ball

Dell (DELL) says it uncovered errors and misconduct in a review of its accounting practices and past financial statements. The stock dropped by as much as 7% after the market closed. But, the company…

Douglas A. McIntyre · 20 years ago

Dendreon Massive Pre-Market

Dendreon (DNDN-NASDAQ) won big yesterday after receiving panel backing from the FDA for Provenge for the treatment  of advanced prostate cancer.  The stock has reopened for trading just a few minutes ago and the…

Douglas A. McIntyre · 20 years ago

Earlybird Analyst Calls (MAR 30, 2007)

ANAD started as Outperform at Credit Suisse.ASCA cut to Underweight at Prudential.BRCM raised to Buy at Stifel Nicolaus.CDR started as Neutral at B of A.DSCM started as Neutral at First Albany.

Douglas A. McIntyre · 20 years ago

Toyota’s New Pick-Up Falters: Welcome To Detroit

Toyota’s (TM) new full-sized pick-up, the Tundra, was supposed to get the Japanese company into a lucrative market dominated by Ford’s (F) F-series and the Chevy (GM) Silverado. But, on the way to another…

Douglas A. McIntyre · 20 years ago

Take-Two Shareholders Are No Better Off

Dissident institutional investors have taken over Take-Two Interactive (TTWO). They have fired the CEO and put in new management. The process of putting the company into play and the general recovery of video game…

Douglas A. McIntyre · 20 years ago

On Buffett, Berkshire, and You

From Gannon On Investing At the end of my post “On Billionaires, Their Buys, and Buffett“, I said “I will follow up with another post on this topic tomorrow. Hopefully, I can give you…

Douglas A. McIntyre · 20 years ago

Baltic Dry Freight Index

From Ticker Sense The Baltic Dry Freight Index is considered by some to be a decent indicator as to the future direction of the economy.  The logic goes along the lines that if shippers…

Douglas A. McIntyre · 20 years ago

The Rising Cost of Healthcare Taken To Another Extreme

By Chad Brand of Peridot Capitalist LOS ANGELES, March 26 (Reuters) – Shares of Alexion Pharmaceuticals Inc. (ALXN) rose more than 9 percent on Monday after the company told analysts that its treatment for…

Douglas A. McIntyre · 20 years ago

Interview With Michael Mauboussin

By Yaser Anwar, CSC of Equity Investment Ideas Michael J. Mauboussin joined Legg Mason Capital Management as Chief Investment Strategist in 2004. Prior to joining LMCM, Michael served as Managing Director and Chief U.S.…

Douglas A. McIntyre · 20 years ago

Lincare Synchs Up Revenues

From AAO Weblog A while ago, I mentioned Apria Healthcare’s SAB 108 adjustment to retained earnings for getting revenues recognition (and expense recognition) in line with when revenues are actually earned. Not too surprising,…

Douglas A. McIntyre · 20 years ago

ART Is Not A Luxury!

by H.S. AyoubBioHealth Investor.com One of the most over-used arguments against assisted reproductive technology (ART) is that couples do not need it. Opponents continually point out that adoption is a great way of giving…

Douglas A. McIntyre · 20 years ago

StreetInsider.com After-Hours Movers 03/29

Cell Genesys, Inc. (Nasdaq: CEGE) 22% HIGHER; related to FDA panel backing of Dendreon’s (Nasdaq: DNDN) Provenge for prostate cancer. CEGE also has a cancer immunotherapy for prostate cancer. Spectrum Control Inc. (Nasdaq: SPEC)…

Douglas A. McIntyre · 20 years ago

Pirate Capital Cuts Stake in Cornell Companies (CRN) to 8.9%

From 13D Tracker In an amended 13D filing on Cornell Companies (NYSE: CRN), Pirate Capital disclosed an 8.9% stake (1.25 million shares) in the company. This is down from the 16.5% stake (2.32 million…

Douglas A. McIntyre · 20 years ago